Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibroma.

Wang C, Sun B, Guo L, Wang X, Ke C, Liu S, Zhao W, Luo S, Guo Z, Zhang Y, Xu G, Li E.

Sci Rep. 2014 Jun 20;4:5383. doi: 10.1038/srep05383.

2.

Exhaled breath volatile biomarker analysis for thyroid cancer.

Guo L, Wang C, Chi C, Wang X, Liu S, Zhao W, Ke C, Xu G, Li E.

Transl Res. 2015 Aug;166(2):188-95. doi: 10.1016/j.trsl.2015.01.005. Epub 2015 Jan 20.

PMID:
25666355
3.

Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.

Mangler M, Freitag C, Lanowska M, Staeck O, Schneider A, Speiser D.

Ginekol Pol. 2012 Oct;83(10):730-6.

PMID:
23383557
4.

Differentiation between genetic mutations of breast cancer by breath volatolomics.

Barash O, Zhang W, Halpern JM, Hua QL, Pan YY, Kayal H, Khoury K, Liu H, Davies MP, Haick H.

Oncotarget. 2015 Dec 29;6(42):44864-76. doi: 10.18632/oncotarget.6269.

5.

Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.

Hicks LC, Huang J, Kumar S, Powles ST, Orchard TR, Hanna GB, Williams HR.

J Crohns Colitis. 2015 Sep;9(9):731-7. doi: 10.1093/ecco-jcc/jjv102. Epub 2015 Jun 12.

PMID:
26071410
6.

Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms.

Phillips M, Beatty JD, Cataneo RN, Huston J, Kaplan PD, Lalisang RI, Lambin P, Lobbes MB, Mundada M, Pappas N, Patel U.

PLoS One. 2014 Mar 5;9(3):e90226. doi: 10.1371/journal.pone.0090226. eCollection 2014 Mar 5.

7.

Breath carbonyl compounds as biomarkers of lung cancer.

Li M, Yang D, Brock G, Knipp RJ, Bousamra M, Nantz MH, Fu XA.

Lung Cancer. 2015 Oct;90(1):92-7. doi: 10.1016/j.lungcan.2015.07.005. Epub 2015 Jul 19.

PMID:
26233567
8.

Noninvasive detection of colorectal cancer by analysis of exhaled breath.

Wang C, Ke C, Wang X, Chi C, Guo L, Luo S, Guo Z, Xu G, Zhang F, Li E.

Anal Bioanal Chem. 2014 Jul;406(19):4757-63. doi: 10.1007/s00216-014-7865-x. Epub 2014 May 13.

PMID:
24820062
9.

Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.

Kumar S, Huang J, Abbassi-Ghadi N, Mackenzie HA, Veselkov KA, Hoare JM, Lovat LB, Španěl P, Smith D, Hanna GB.

Ann Surg. 2015 Dec;262(6):981-90. doi: 10.1097/SLA.0000000000001101.

PMID:
25575255
10.

The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.

Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P, Ying K.

Cancer Biomark. 2012;11(4):129-37. doi: 10.3233/CBM-2012-00270.

PMID:
23144150
11.

Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation.

Wang C, Dong R, Wang X, Lian A, Chi C, Ke C, Guo L, Liu S, Zhao W, Xu G, Li E.

Sci Rep. 2014 Dec 8;4:7312. doi: 10.1038/srep07312.

12.

Detection of precancerous gastric lesions and gastric cancer through exhaled breath.

Amal H, Leja M, Funka K, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Haick H.

Gut. 2016 Mar;65(3):400-7. doi: 10.1136/gutjnl-2014-308536. Epub 2015 Apr 13.

PMID:
25869737
13.

Volatile signature for the early diagnosis of lung cancer.

Gasparri R, Santonico M, Valentini C, Sedda G, Borri A, Petrella F, Maisonneuve P, Pennazza G, D'Amico A, Di Natale C, Paolesse R, Spaggiari L.

J Breath Res. 2016 Feb 9;10(1):016007. doi: 10.1088/1752-7155/10/1/016007.

PMID:
26857451
14.

Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet.

Baranska A, Tigchelaar E, Smolinska A, Dallinga JW, Moonen EJ, Dekens JA, Wijmenga C, Zhernakova A, van Schooten FJ.

J Breath Res. 2013 Sep;7(3):037104. doi: 10.1088/1752-7155/7/3/037104. Epub 2013 Jun 18.

PMID:
23774130
15.

Volatile markers of breast cancer in the breath.

Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Rahbari-Oskoui F, Wong C.

Breast J. 2003 May-Jun;9(3):184-91. Erratum in: Breast J. 2003 Jul-Aug;9(4):345.

PMID:
12752626
16.

Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.

Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI.

Thorax. 2009 Sep;64(9):744-8. doi: 10.1136/thx.2008.099465. Epub 2009 Jan 21.

PMID:
19158121
17.

Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.

Kubáň P, Foret F.

Anal Chim Acta. 2013 Dec 17;805:1-18. doi: 10.1016/j.aca.2013.07.049. Epub 2013 Jul 31. Review.

PMID:
24296139
18.

Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.

Mochalski P, King J, Haas M, Unterkofler K, Amann A, Mayer G.

BMC Nephrol. 2014 Mar 8;15:43. doi: 10.1186/1471-2369-15-43.

19.

Blood volatile compounds as biomarkers for colorectal cancer.

Wang C, Li P, Lian A, Sun B, Wang X, Guo L, Chi C, Liu S, Zhao W, Luo S, Guo Z, Zhang Y, Ke C, Ye G, Xu G, Zhang F, Li E.

Cancer Biol Ther. 2014 Feb;15(2):200-6. doi: 10.4161/cbt.26723. Epub 2013 Nov 1.

20.

Breath analysis by mass spectrometry: a new tool for breast cancer detection?

Patterson SG, Bayer CW, Hendry RJ, Sellers N, Lee KS, Vidakovic B, Mizaikoff B, Gabram-Mendola SG.

Am Surg. 2011 Jun;77(6):747-51.

PMID:
21679645

Supplemental Content

Support Center